NCT00652496 - Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

249

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

Bimatoprost 0.01% ophthalmic solution

One drop in one eye, once daily in the morning for 4 consecutive days, the other eye received the active control eye drop

DRUG

Bimatoprost 0.015% formulation 1 ophthalmic solution

One drop in one eye, once daily in the morning for 4 consecutive days, the other eye received the active control eye drop

DRUG

Bimatoprost 0.015% formulation 2 ophthalmic solution

One drop in one eye, once daily in the morning for 4 consecutive days, the other eye received the active control eye drop

DRUG

Bimatoprost 0.02% ophthalmic solution

One drop in one eye, once daily in the morning for 4 consecutive days, the other eye received the active control eye drop

DRUG

Bimatoprost 0.03% ophthalmic solution

Bimatoprost 0.03% ophthalmic solution, one drop in one eye, once daily in the morning for 4 consecutive days, the other eye received one drop of any of the 4 study drugs

Trial Locations (1)

Unknown

Wenatchee